AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
BECLOMETHASONE DIPROPIONATE in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| IBICAR 200 INHALATION | 2025/22.1.3/6954 | GLENMARK PHARMACEUTICAL LIMITED | active | 8 May 2030 |
| IBICAR 50 SOLUTION | 2025/22.1.3/6952 | GLENMARK PHARMACEUTICAL LIMITED | active | 8 May 2030 |
| IBICAR 100 AEROSOL; INHALATION | 2025/22.1.3/6953 | GLENMARK PHARMACEUTICAL LIMITED | active | 8 May 2030 |
| BECLATE 200 INHALATION | 2010/22.1.3/4630 | CIPLA LTD | active | 31 Dec 2027 |
| BECLATE 50 INHALATION | 2010/22.1.3/4631 | CIPLA LTD | active | 31 Dec 2027 |
BECLOMETHASONE DIPROPIONATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing BECLOMETHASONE DIPROPIONATE, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track BECLOMETHASONE DIPROPIONATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.